| |
|
|
| Name: |
Lynx1 Capital Management LP |
| City: |
HUMACAO |
| State: |
PR |
| Zip: |
00791 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
9 |
|
View All Holdings |
Currently
Viewing:
Increased Positions |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
ALPN |
Alpine Immune Sciences Inc |
1 |
- |
$64.94 |
$72,693,000 |
3,813,926 |
28.58% |
45,160,000 |
1,409,312 |
8.307 |
N/A |
|
|
CABA |
Cabaletta Bio, Inc. |
2 |
- |
$0.00 |
$47,906,000 |
2,110,401 |
18.84% |
15,853,000 |
4,401 |
8.158 |
N/A |
|
|
CCCC |
C4 Therapeutics, Inc. |
5 |
- |
$0.00 |
$17,709,000 |
3,134,396 |
6.96% |
15,813,000 |
2,115,166 |
7.284 |
N/A |
|
|
STOK |
Stoke Therapeutics, Inc. |
6 |
- |
$0.00 |
$15,553,000 |
2,956,918 |
6.12% |
8,815,000 |
1,246,764 |
6.214 |
N/A |
|
|
AUTL |
Autolus Therapeutics Plc |
7 |
- |
$3.99 |
$11,968,000 |
1,858,409 |
4.71% |
8,792,000 |
495,384 |
1.074 |
N/A |
|
|
GHRS |
Gh Research Ord Shs |
8 |
- |
$0.00 |
$10,664,000 |
1,838,617 |
4.19% |
-423,000 |
735,439 |
3.764 |
N/A |
|
|
BNOX |
Bionomics Ads |
13 |
- |
$0.00 |
$1,220,000 |
824,305 |
0.48% |
-982,000 |
8,793 |
10.962 |
N/A |
|
|
NKTR |
Nektar Therapeutics |
14 |
- |
$1.76 |
$1,090,000 |
1,929,198 |
0.43% |
38,000 |
162,383 |
1.075 |
Drug Delivery |
|
|
PASG |
Passage Bio, Inc. |
15 |
- |
$1.47 |
$383,000 |
379,159 |
0.15% |
258,000 |
189,035 |
0.833 |
N/A |
|
